• Pharma firms hopeful for year ahead

Preparative

Pharma firms hopeful for year ahead

Pharma firms around the world are broadly hopeful about revenue growth over the next 12 months, according to a new study.

Nearly half – 47 per cent – of respondents to the study by iCD Research said they were "more optimistic" about growth.

Some 28 per cent said they were "neutral" and 23 per cent said they were less optimistic.

However, ongoing economic concerns have led to firms revising down their forecasts, with global economic growth projected to be 2.5 per cent in 2012 and 3.1 per cent in 2013.

This is down from estimates of 3.6 per cent. Market turmoil in Europe and lagging growth in emerging economies are fuelling the revised forecasts, iCD said.

But emerging markets – China, India and Brazil – are set to see positive growth rates this year, spearheaded by China, which will enjoy double digit growth on the back of a successful 2011.

According to separate research by Espicom, the UK pharma market is set to experience moderate growth over the coming years.

Posted by Fiona Griffiths


Events

ASMS Conference

Jun 01 2025 Baltimore, MD, USA

HPLC 2025

Jun 15 2025 Bruges, Belgium

LabAsia 2025

Jul 14 2025 Kuala Lumpur, Malaylsia

SinS Solutions in Science

Jul 15 2025 Brighton, UK

ACS National Meeting - Fall 2025

Aug 17 2025 Washington DC, USA & Virtual

View all events